Tag Archive for: AbbVie

BaseLaunch announces a new partnership with AbbVie

/in

Media release Basel, Switzerland, 22.05.2024 BaseLaunch announces a new partnership with AbbVie Further strengthens BaseLaunch’s global pharma industry partnerships 24 early-stage biotech ventures have now been supported by BaseLaunch Portfolio companies have raised over US$ 600 million in equity capital BaseLaunch, the Basel-based biotech venture incubator, today announces that AbbVie has become its newest partner. […]

Read more

Novo Holdings Portfolio Company Syndesi Therapeutics acquired by AbbVie

/in

March 1, 2022 Deal value of US$ 1 billion with US$ 130 million upfront Novo Holdings co-created Syndesi Therapeutics in partnership with UCB Pharma and co-led the Series A financing Syndesi’s lead program SDI-118 to be accelerated by AbbVie to the benefit of patients suffering from cognitive impairment associated with a range of neurodegenerative and […]

Read more